Search Results

There are 12794 results for: content related to: EFFECTS OF ANTIHYPERTENSIVE DRUGS IN THE PREVENTION OF NEW-ONSET DIABETES MELLITUS IN PATIENTS WITH HYPERTENSION AT HIGH-RISK OF CARDIOVASCULAR EVENTS IN RELATION TO AGING

  1. You have free access to this content
    Candesartan

    Cardiovascular Drug Reviews

    Volume 22, Issue 4, December 2004, Pages: 263–284, Christoph H. Gleiter, Christine Jägle, Ursula Gresser and Klaus Mörike

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2004.tb00146.x

  2. You have free access to this content
    Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis

    British Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 1999, Pages: 645–651, Marc Pfister, Franziska Schaedeli, Felix J. Frey and Dominik E. Uehlinger

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00939.x

  3. You have free access to this content
    Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder

    International Journal of Urology

    Volume 19, Issue 5, May 2012, Pages: 457–464, Ken Aikawa, Takio Sakai, Kei Ishibashi, Homare Shiomi, Koji Sagawa, Shin Kumagai, Masao Kataoka, Hidenori Akaihata and Osamu Yamaguchi

    Article first published online : 9 FEB 2012, DOI: 10.1111/j.1442-2042.2012.02965.x

  4. ACUTE EFFECTS OF CANDESARTAN ON RAT RENAL HAEMODYNAMICS AND PROXIMAL TUBULAR REABSORPTION

    Clinical and Experimental Pharmacology and Physiology

    Volume 32, Issue 9, September 2005, Pages: 714–720, Siriphun Hiranyachattada, Siriwan Saetew and Peter J Harris

    Article first published online : 20 SEP 2005, DOI: 10.1111/j.1440-1681.2005.04253.x

  5. You have free access to this content
    Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion

    Experimental Physiology

    Volume 94, Issue 8, August 2009, Pages: 937–946, Adam P. Mecca, Timothy E. O'Connor, Michael J. Katovich and Colin Sumners

    Article first published online : 17 JUN 2009, DOI: 10.1113/expphysiol.2009.047936

  6. Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer

    Human Cell

    Volume 20, Issue 1, February 2007, Pages: 1–9, Michio KOSUGI, Akira MIYAJIMA, Eiji KIKUCHI, Takeo KOSAKA, Yutaka HORIGUCHI and Masaru MURAI

    Article first published online : 14 MAY 2007, DOI: 10.1111/j.1749-0774.2007.00025.x

  7. You have free access to this content
    Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme

    European Journal of Heart Failure

    Volume 12, Issue 7, July 2010, Pages: 738–745, Su Min Chang, Christopher B. Granger, Peter A. Johansson, Peter Kosolcharoen, John J.V. McMurray, Eric L. Michelson, David R. Murray, Bertil Olofsson, Marc A. Pfeffer, Scott D. Solomon, Karl Swedberg, Salim Yusuf, Mark E. Dunlap and for the CHARM Investigators

    Article first published online : 13 JAN 2014, DOI: 10.1093/eurjhf/hfq065

  8. You have free access to this content
    Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man

    British Journal of Clinical Pharmacology

    Volume 45, Issue 6, June 1998, Pages: 567–573, Claudius Malerczyk, Bettina Fuchs, Gustav G. Belz, Susanna Roll, Raunhild Butzer, Kerstin Breithaupt-Grögler, Volker Herrmann, Steffen G. Magin, Anette Högemann, Barbara Voith and Ernst Mutschler

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00722.x

  9. You have free access to this content
    Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The CLAIM Study

    The Journal of Clinical Hypertension

    Volume 3, Issue 1, January/February 2001, Pages: 16–21, George Bakris, 1 Alan Gradman, 2 Max Reif, 3 Marian Wofford, 4 Mark Munger, 5 Susan Harris, 6 Jennifer Vendetti, 6 Eric L. Michelson and 6 Rebecca Wang 6

    Article first published online : 31 MAY 2007, DOI: 10.1111/j.1524-6175.2001.00826.x

  10. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST)

    International Journal of Stroke

    Volume 10, Issue 6, August 2015, Pages: 830–835, Astrid G. Hornslien, Else C. Sandset, Jannicke Igland, Andreas Terént, Gudrun Boysen, Philip M. W. Bath, Gordon D. Murray and Eivind Berge

    Article first published online : 22 MAR 2015, DOI: 10.1111/ijs.12477

  11. You have free access to this content
    AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR

    British Journal of Pharmacology

    Volume 142, Issue 5, July 2004, Pages: 821–830, Xiao C Li and Robert E Widdop

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705838

  12. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Michelle MY Wong, Inderjit K Heran and James M Wright

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD003822.pub2

  13. Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation

    European Journal of Clinical Investigation

    Volume 41, Issue 6, June 2011, Pages: 652–658, Maria G. Pavlatou, George Mastorakos, Alexandra Margeli, Evangelia Kouskouni, Nicholas Tentolouris, Nikos Katsilambros, George P. Chrousos and Ioannis Papassotiriou

    Article first published online : 22 DEC 2010, DOI: 10.1111/j.1365-2362.2010.02453.x

  14. You have full text access to this OnlineOpen article
    Effects of candesartan, an angiotensin II receptor type I blocker, on atrial remodeling in spontaneously hypertensive rats

    Physiological Reports

    Volume 3, Issue 1, January 2015, Stéphanie C. Choisy, Shang-Jin Kim, Jules C. Hancox, Sandra A. Jones and Andrew F. James

    Article first published online : 27 JAN 2015, DOI: 10.14814/phy2.12274

  15. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring

    International Journal of Clinical Practice

    Volume 60, Issue 4, April 2006, Pages: 391–398, J-P Baguet, 1 S. Nisse-Durgeat, 2 S. Mouret, 1 R. Asmar and 3 J-M Mallion 1

    Article first published online : 20 MAR 2006, DOI: 10.1111/j.1368-5031.2006.00903.x

  16. You have free access to this content
    Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial

    European Journal of Heart Failure

    Volume 10, Issue 2, February 2008, Pages: 157–163, R.A.P. Weir, John J.V. McMurray, Margareta Puu, Scott D. Solomon, Bertil Olofsson, Christopher B. Granger, Salim Yusuf, Eric L. Michelson, Karl Swedberg, Marc A. Pfeffer and CHARM Investigators

    Article first published online : 13 JAN 2014, DOI: 10.1016/j.ejheart.2007.12.006

  17. You have free access to this content
    Role of NF-κβ and Oxidative Pathways in Atherosclerosis: Cross-Talk Between Dyslipidemia and Candesartan

    Cardiovascular Therapeutics

    Volume 31, Issue 6, December 2013, Pages: 381–387, Najah R. Hadi, Nasser Ghaly Yousif, Mohammed S. Abdulzahra, Bassim I. Mohammad, Fadhil G. al-amran, Murooge L. Majeed and Maitham G. Yousif

    Article first published online : 27 NOV 2013, DOI: 10.1111/1755-5922.12033

  18. You have free access to this content
    Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis

    International Journal of Clinical Practice

    Volume 65, Issue 3, March 2011, Pages: 253–263, A. M. Grosso, P. N. Bodalia, R. J. MacAllister, A. D. Hingorani, J. C. Moon and M. A. Scott

    Article first published online : 1 FEB 2011, DOI: 10.1111/j.1742-1241.2011.02633.x

  19. Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 5, May 2015, Pages: 537–548, Tong Zhu, Antonia G Miller, Devy Deliyanti, David R Berka, Alex Agrotis, Duncan J Campbell and Jennifer L Wilkinson-Berka

    Article first published online : 23 APR 2015, DOI: 10.1111/1440-1681.12376

  20. You have free access to this content
    Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan

    The Journal of Clinical Hypertension

    Volume 13, Issue 3, March 2011, Pages: 189–197, David Russell, Jan Stålhammar, Johan Bodegard, Pål Hasvold, Marcus Thuresson and Sverre E. Kjeldsen

    Article first published online : 22 DEC 2010, DOI: 10.1111/j.1751-7176.2010.00410.x